Join Us March 13th @ 1 pm ET BEFORE Nvidia’s “Q-Day”

In 2016 Louis Navellier made a big prediction regarding Nvidia’s GPUs... It went up more than 7,000% at its peak. Don’t miss Louis NEXT Nvidia call. (Plus 6 stocks you need to own before March 20th.)

Thu, March 13 at 10:00AM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Exit Alert: 3 Stocks to Offload Before the Downturn

By Yiannis Zourmpanos, InvestorPlace Contributor
Discover why three top stocks to sell now are facing challenges in technology hardware, pharmaceuticals and automobile manufacturers.

TEM Stock IPO: 7 Things to Know as Tempus AI Starts Trading Today

By Samuel O'Brient, InvestorPlace Reporter
Tempus AI begins trading today on the Nasdaq and is valued at $6 billion. Here's what to know about the new TEM stock.

Why Is Bio-Path (BPTH) Stock Up 20% Today?

By William White, InvestorPlace Writer
Bio-Path stock is up on Friday with heavy trading of NPTH shares after the company posited positive interim data from a Phase 2 study.

Bullish Bets: 3 Stocks Getting the Green Light From Wall Street

By Stavros Tousios, InvestorPlace Contributor
Colliers International, Elevance Health and US Foods are three food stocks to buy that have recently earned Wall Street's seal of approval.

Why Is Gain Therapeutics (GANX) Stock Down 25% Today?

By William White, InvestorPlace Writer
Gain Therapeutics stock is down on Friday after the company priced an $11 million public offering for roughly 7 million shares of GANX.

Why Is Nexalin Technology (NXL) Stock Down 29% Today?

By William White, InvestorPlace Writer
Nexalin Technology stock is down on Friday after shares of NXL rallied yesterday alongside approval for its neurostimulation device.

Why Is Foxo Technologies (FOXO) Stock Up 55% Today?

By William White, InvestorPlace Writer
Foxo Technologies stock is up on Friday with heavy trading after the company announced to acquisition deals with Rennova Health.

The 3 Most Undervalued AI Penny Stocks to Buy in June 2024

By Chris Markoch, InvestorPlace Contributor
As AI continues to evolve, it may be time for patient investors to look for the most undervalued AI penny stocks.

7 A-Rated Biotech Stocks Worth Betting on in June

By Louis Navellier and the InvestorPlace Research Staff
A-rated biotech stocks are highly coveted because they are at the forefront — or in the midst of — groundbreaking innovation.

3 Stocks Under $5 You Should Buy Now: June 2024

By Rich Duprey, InvestorPlace Contributor
It's not often stocks under $5 to buy will generate enormous returns, but these three stocks are poised for a breakthrough.

Medical Debt Hurting Your Credit Score? How Biden’s New Plan Could Fix That

By Chris MacDonald, InvestorPlace Contributor
Let's dive into a new plan from the Biden Administration aimed at helping those with credit score issues and medical debt navigate the system.

3 Stocks Under $10 Set to Quadruple by 2025: June Edition

By Ian Cooper, InvestorPlace Contributor
Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst.

Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget

By Josh Enomoto, InvestorPlace Contributor
Fundamentally, biotech stocks to buy operate on a clear and unavoidable narrative: wealth means nothing without health. You hear various stories about extremely wealthy tycoons…

Payout Powerhouses: 7 Dividend Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor
Just like in arguably most sports, balance is everything. The same applies to dividend stocks to buy. Yes, the high-flying growth names tend to attract…

Why Is Sharps Technology (STSS) Stock Up 21% Today?

By William White, InvestorPlace Writer
Sharps Technology stock is up on Thursday with heavy trading of STSS shares after the company signed a $30 million purchase order.

Why Is BioRestorative Therapies (BRTX) Stock Up 42% Today?

By William White, InvestorPlace Writer
BioRestorative Therapies stock is up on Thursday with heavy trading of BRTX shares after announcing licensing negotiations.

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns

By Rich Duprey, InvestorPlace Contributor
Wall Street says these three deeply discounted stocks for double-digit returns over the next year have an average implied upside of 83%.

The 3 Most Undervalued Penny Stocks to Buy in June 2024

By Steve Booyens, CFA
Numerous penny stocks are undervalued and might benefit from elevated trading activity, given their fundamental zeal.

Why Is Cara Therapeutics (CARA) Stock Down 27% Today?

By William White, InvestorPlace Writer
Cara Therapeutics stock is down on Thursday as investors learn of a failed clinical trial and the company considering strategic alternatives.
Load More Articles